Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Larsen

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Bioorganic & Medicinal Chemistry|November 16, 2018
PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical developmentSteven P Tanis, Jerry R Colca, Timothy T Parker, et al.
Journal of Medicinal Chemistry|June 11, 2008
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductaseRonald W Sarver, Elizabeth Bills, Gary Bolton, et al.
ACS Pharmacology & Translational Science|February 11, 2020
Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic CompoundsErika M Lisabeth, Dylan Kahl, Indiwari Gopallawa, et al.
ACS Chemical Neuroscience|February 7, 2020
Discovery and Optimization of Triazine Nitrile Inhibitors of <i>Toxoplasma gondii</i> Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNSJeffery D Zwicker, David Smith, Alfredo J Guerra, et al.
ACS Chemical Neuroscience|October 9, 2020
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3Michael W Wilson, Liming Shu, Vania Hinkovska-Galcheva, et al.
Journal of Biomedical Nanotechnology|October 22, 2015
Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast CancersMagesh Muthu, Jaganmohan Somagoni, Vino T Cheriyan, et al.
Journal of Medicinal Chemistry|September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer ChemotherapyBrandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
Journal of Medicinal Chemistry|April 7, 2016
Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 InhibitorsHelen V Waldschmidt, Kristoff T Homan, Osvaldo Cruz-Rodríguez, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Chulho Choi, Yuntao Song, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry|November 16, 2018
PPARγ-sparing thiazolidinediones as insulin sensitizers. Design, synthesis and selection of compounds for clinical developmentSteven P Tanis, Jerry R Colca, Timothy T Parker, et al.
Journal of Medicinal Chemistry|June 11, 2008
Thermodynamic and structure guided design of statin based inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductaseRonald W Sarver, Elizabeth Bills, Gary Bolton, et al.
ACS Pharmacology & Translational Science|February 11, 2020
Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic CompoundsErika M Lisabeth, Dylan Kahl, Indiwari Gopallawa, et al.
ACS Chemical Neuroscience|February 7, 2020
Discovery and Optimization of Triazine Nitrile Inhibitors of <i>Toxoplasma gondii</i> Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNSJeffery D Zwicker, David Smith, Alfredo J Guerra, et al.
ACS Chemical Neuroscience|October 9, 2020
Optimization of Eliglustat-Based Glucosylceramide Synthase Inhibitors as Substrate Reduction Therapy for Gaucher Disease Type 3Michael W Wilson, Liming Shu, Vania Hinkovska-Galcheva, et al.
Journal of Biomedical Nanotechnology|October 22, 2015
Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast CancersMagesh Muthu, Jaganmohan Somagoni, Vino T Cheriyan, et al.
Journal of Medicinal Chemistry|September 18, 2018
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer ChemotherapyBrandt C Huddle, Edward Grimley, Cameron D Buchman, et al.
Journal of Medicinal Chemistry|April 7, 2016
Structure-Based Design, Synthesis, and Biological Evaluation of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 InhibitorsHelen V Waldschmidt, Kristoff T Homan, Osvaldo Cruz-Rodríguez, et al.
Bioorganic & Medicinal Chemistry Letters|June 19, 2007
Design and synthesis of novel, conformationally restricted HMG-CoA reductase inhibitorsJeffrey A Pfefferkorn, Chulho Choi, Yuntao Song, et al.
Molecular Cancer Therapeutics|November 13, 2016
Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing MelanomaAndrew J Haak, Kathryn M Appleton, Erika M Lisabeth, et al.
Pageof 9